Skip to main content

Coats Lonnel

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Coats Lonnel as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

BPMC Blueprint Medicines Corp

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 22, 2024 (view filing)Nov 20-212 daysCoats LonnelDirectorSSale−19.8K$94.31−$1.87M−89.8%2.24K after4 lots10b5-1

LXRX Lexicon Pharmaceuticals, Inc.

Chief Executive Officer5 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 17, 2023 (view filing)Nov 161 dayCoats LonnelChief Executive OfficerPPurchase+90.0K$1.05+$94.5K+10.9%914.4K after
Nov 13, 2023 (view filing)Nov 103 daysCoats LonnelChief Executive OfficerPPurchase+10.0K$1.01+$10.1K+1.2%824.4K after
Jun 29, 2023 (view filing)Jun 29Same dayCoats LonnelChief Executive OfficerPPurchase+10.0K$2.16+$21.6K+1.2%814.4K after
Jun 26, 2023 (view filing)Jun 23-263 daysCoats LonnelChief Executive OfficerPPurchase+20.0K$2.34+$46.8K+2.5%804.4K after2 lots
Jun 22, 2023 (view filing)Jun 22Same dayCoats LonnelChief Executive OfficerPPurchase+40.0K$2.31+$92.4K+5.4%784.4K after